SciELO - Scientific Electronic Library Online

 
vol.50 suppl.4Uso de antibióticos en México: revisión de problemas y políticasCompetencia y precios en el mercado farmacéutico mexicano índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Journal

Artigo

Indicadores

Links relacionados

  • Não possue artigos similaresSimilares em SciELO

Compartilhar


Salud Pública de México

versão impressa ISSN 0036-3634

Resumo

GONZALEZ PIER, Eduardo. Healthy pharmaceutical policy. Salud pública Méx [online]. 2008, vol.50, suppl.4, pp.S488-S495. ISSN 0036-3634.

Today, the pharmaceutical industry is experiencing a profound transition. Globalization and technological advancement represent the principal pressures for change in the market, where it is increasingly more difficult for this type of industry to efficiently recoup the growing cost of innovation. Mexico needs to analyze the policy implications of these change factors and promote, in the pharmaceutical market, policies that maximize health gains on invested resources. Pharmaceutical policy offers a rare example for a complementary approach between a sound health policy and an efficient economic policy; that is, a "healthy pharmaceutical policy."

Palavras-chave : drug industry; drug and narcotic control; national drug policy; innovation; Mexico.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )

 

Creative Commons License Todo o conteúdo deste periódico, exceto onde está identificado, está licenciado sob uma Licença Creative Commons